ATE444078T1 - Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen - Google Patents

Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen

Info

Publication number
ATE444078T1
ATE444078T1 AT01960261T AT01960261T ATE444078T1 AT E444078 T1 ATE444078 T1 AT E444078T1 AT 01960261 T AT01960261 T AT 01960261T AT 01960261 T AT01960261 T AT 01960261T AT E444078 T1 ATE444078 T1 AT E444078T1
Authority
AT
Austria
Prior art keywords
growth hormone
human growth
pluripotent
stem cells
mobilization
Prior art date
Application number
AT01960261T
Other languages
English (en)
Inventor
Alessandro GIANNI
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE444078T1 publication Critical patent/ATE444078T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01960261T 2000-06-07 2001-06-01 Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen ATE444078T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111834 2000-06-07
PCT/EP2001/006249 WO2001093900A1 (en) 2000-06-07 2001-06-01 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
ATE444078T1 true ATE444078T1 (de) 2009-10-15

Family

ID=8168902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960261T ATE444078T1 (de) 2000-06-07 2001-06-01 Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen

Country Status (10)

Country Link
US (1) US20040028649A1 (de)
EP (1) EP1286689B1 (de)
JP (1) JP2003535144A (de)
AT (1) ATE444078T1 (de)
AU (2) AU8180001A (de)
CA (1) CA2409197A1 (de)
DE (1) DE60140051D1 (de)
ES (1) ES2330193T3 (de)
IL (1) IL153288A0 (de)
WO (1) WO2001093900A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
EP1016413A1 (de) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen
US7288521B2 (en) * 2000-04-06 2007-10-30 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
CA2467557A1 (en) * 2001-11-19 2003-05-30 Kyowa Hakko Kogyo Co., Ltd. Agent which mobilizes multipotential stem cells from tissues to peripheral blood
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
WO2005017160A2 (en) * 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2005017161A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Chimeric peptides for the regulation of gtpases
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
CA2542834C (en) 2003-10-21 2012-04-24 Igf Oncology, Llc Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
WO2005072292A2 (en) * 2004-01-24 2005-08-11 Hugh Mctavish Methods for enhancing radiation therapy
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
WO2006047214A2 (en) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
CA2677813A1 (en) * 2007-02-13 2008-08-21 Helsinn Therapeutics (U.S.), Inc. Method of treating cell proliferative disorders using growth hormone secretagogues
US20100226894A1 (en) * 2009-03-09 2010-09-09 Alex Wah Hin Yeung Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
SG192254A1 (en) * 2011-01-31 2013-08-30 Royal Medical Group Pllc Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
CN104302670A (zh) 2012-02-07 2015-01-21 Phi生物医药股份有限公司 制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体
CA2936675C (en) 2014-01-12 2023-06-27 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
CN117442747A (zh) 2017-05-21 2024-01-26 Igf肿瘤公司 胰岛素样生长因子——用于治疗骨髓增生异常综合症的化学治疗缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549232C2 (de) * 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
EP1016414B1 (de) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
EP1016413A1 (de) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen

Also Published As

Publication number Publication date
AU2001281800B2 (en) 2005-12-22
US20040028649A1 (en) 2004-02-12
JP2003535144A (ja) 2003-11-25
ES2330193T3 (es) 2009-12-07
WO2001093900A1 (en) 2001-12-13
CA2409197A1 (en) 2001-12-13
EP1286689A1 (de) 2003-03-05
IL153288A0 (en) 2003-07-06
EP1286689B1 (de) 2009-09-30
DE60140051D1 (de) 2009-11-12
AU8180001A (en) 2001-12-17

Similar Documents

Publication Publication Date Title
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
MXPA03006699A (es) Metodos de induccion de tolerancia al trasplante de organos y correccion de hemoglobinopatias.
BR112021021165A2 (pt) Conjugados anticorpo-fármaco de amatoxina e uso dos mesmos
GB2434157A (en) Platelets from stem cells
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
WO2005044179A3 (en) Formulations containing astragalus extracts and uses thereof
WO2003059276A3 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
WO2003099225A3 (en) Compositions for delivering nucleic acids to cells
ITNA20040043A1 (it) Tecnica di ingegneria tissutale ottenibile mediante isolamento di una nuova sottopopolazione di cellule staminali mbp-shed ed mbp-dpsc, isolate da polpa di denti decidui e permanenti in grado di produrre in vitro tessuto osseo umano.
Samiei et al. The effect of electromagnetic fields on survival and proliferation rate of dental pulp stem cells
EA200700613A1 (ru) Метаболически активные микроорганизмы и способы их получения
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
IL156628A (en) Use of nk t cells in medical preparation, preparations containing nk t cells and their use in the treatment of immune-related disorders
RU2006146795A (ru) Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
EA200401586A1 (ru) Композиции для терапевтического использования, включающие витамин а, соль металла и инсулин либо гормон роста
DE69528473D1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
WO2009116088A8 (en) Stem cell composition for inducing transplant tolerance
DE60331228D1 (de) Granzyme b als ein hsp70/hsp70 peptid-abhängige apoptoseauslöser in tumorzellen
WO2024077153A8 (en) Pluripotent stem cell-derived megakaryocytes and platelets
ATE431399T1 (de) Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit
Park et al. Stem Cell-Based Therapies for Hair Loss: What is the Evidence from a Clinical Perspective?
WO2002089727A3 (en) Methods of using cytokine c17

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties